BackFive Prime Therapeutics Overview

Five Prime Therapeutics Selling, General & Admin

Selling, General & Admin expenses for FPRX.

Quarterly SG&A Expenses

$8.36M
↓ 10.81% YoY

As of Dec 31, 2020

Annual SG&A Expenses (TTM)

$40.56M
↓ 5.13% YoY

Trailing 12 months ending Dec 31, 2020

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin